Abstract:T-2 toxin is the most toxic trichothecene mycotoxin, and it exerts potent toxic effects, including immunotoxicity, neurotoxicity, and reproductive toxicity. Recently, several novel metabolites, including 3′,4′-dihydroxy-T-2 toxin and 4′,4′-dihydroxy-T-2 toxin, have been uncovered. The enzymes CYP3A4 and carboxylesterase contribute to T-2 toxin metabolism, with 3′-hydroxy-T-2 toxin and HT-2 toxin as the corresponding primary products. Modified forms of T-2 toxin, including T-2–3-glucoside, exert their immunotoxic effects by signaling through JAK/STAT but not MAPK. T-2–3-glucoside results from hydrolyzation of the corresponding parent mycotoxin and other metabolites by the intestinal microbiota, which leads to enhanced toxicity. Increasing evidence has shown that autophagy, hypoxia-inducible factors, and exosomes are involved in T-2 toxin-induced immunotoxicity. Autophagy promotes the immunosuppression induced by T-2 toxin, and a complex crosstalk between apoptosis and autophagy exists. Very recently, “immune evasion” activity was reported to be associated with this toxin; this activity is initiated inside cells and allows pathogens to escape the host immune response. Moreover, T-2 toxin has the potential to trigger hypoxia in cells, which is related to activation of hypoxia-inducible factor and the release of exosomes, leading to immunotoxicity. Based on the data from a series of human exposure studies, free T-2 toxin, HT-2 toxin, and HT-2–4-glucuronide should be considered human T-2 toxin biomarkers in the urine. The present review focuses on novel findings related to the metabolism, immunotoxicity, and human exposure assessment of T-2 toxin and its modified forms. In particular, the immunotoxicity mechanisms of T-2 toxin and the toxicity mechanism of its modified form, as well as human T-2 toxin biomarkers, are discussed. This work will contribute to an improved understanding of the immunotoxicity mechanism of T-2 toxin and its modified forms.

Effective Protective Agents Against the Organ Toxicity of T-2 Toxin and Corresponding Detoxification Mechanisms: A Narrative Review

Overview of T-2 Toxin Enterotoxicity: From Toxic Mechanisms and Detoxification to Future Perspectives

T-2 toxin metabolism and its hepatotoxicity: New insights on the molecular mechanism and detoxification

Advance on researches of production, toxicity and detoxification of T-2 toxin.

The toxicity of acute exposure to T-2 toxin evaluated by the metabonomics technique.

T-2 toxin, a trichothecene mycotoxin: review of toxicity, metabolism, and analytical methods.

T-2 Toxin and Its Cardiotoxicity: New Insights on the Molecular Mechanisms and Therapeutic Implications.

T-2 toxin neurotoxicity: role of oxidative stress and mitochondrial dysfunction

An in-depth review of the dermal toxicity of T-2 toxin: Clinical symptoms, injury mechanisms, and treatment approach

T-2 Toxin—The Most Toxic Trichothecene Mycotoxin: Metabolism, Toxicity, and Decontamination Strategies

Effective Protective Agents Against Organ Toxicity of Deoxynivalenol and Their Detoxification Mechanisms: A Review.

An update on T2-toxins: metabolism, immunotoxicity mechanism and human assessment exposure of intestinal microbiota

An update on T-2 toxin and its modified forms: metabolism, immunotoxicity mechanism, and human exposure assessment

T-2 mycotoxin: toxicological effects and decontamination strategies

Review of the Reproductive Toxicity of T-2 Toxin

A review of anorexia induced by T-2 toxin

T-2 toxin-induced intestinal damage with dysregulation of metabolism, redox homeostasis, inflammation, and apoptosis in chicks

Oxidative stress-mediated cytotoxicity and metabolism of T-2 toxin and deoxynivalenol in animals and humans: an update

Integrated of multi-omics and molecular docking reveal PHGDH, PSAT1 and PSPH in the serine synthetic pathway as potential targets of T-2 toxin exposure in pig intestinal tract

Comprehensive transcriptomic profiling of T-2 toxin-induced nephrotoxicity in mice

Brain damage and neurological symptoms induced by T-2 toxin in rat brain.